Related Experiment Video
Updated: Mar 18, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Immunotherapy for Head and Neck Squamous Cell Carcinoma
Rebecca C Hoesli1, Jeffrey S Moyer1
1University of Michigan, 1500 East Medical Center Drive - SPC 5312, Ann Arbor, MI 48109.
Abstract:
Head and neck squamous cell carcinoma has been found to be an immunosuppressive malignancy, with many defects in the host immune system contributing to the progression of disease. A greater understanding of these defects has lead to the identification and investigation of new therapeutic strategies, targeting immune system dysfunction in an effort to improve the outcomes of this disease. This article provides a brief review of the knowledge regarding the immune defects present in head and neck cancer, as well as a review of the current therapeutic strategies being investigated for use.
Insights
Head and neck squamous cell carcinoma is an immunosuppressive cancer. Understanding immune defects is leading to new therapies targeting immune dysfunction to improve patient outcomes.
Area of Science:
- Oncology
- Immunology
Background:
- Head and neck squamous cell carcinoma (HNSCC) is characterized by an immunosuppressive tumor microenvironment.
- Defects in the host immune system contribute significantly to HNSCC progression and poor prognosis.
Purpose of the Study:
- To review current knowledge of immune defects in HNSCC.
- To discuss emerging therapeutic strategies targeting immune dysfunction in HNSCC.
Main Methods:
- Literature review of studies on HNSCC immunology.
- Analysis of therapeutic strategies investigated for HNSCC.
Main Results:
- Identified key immune defects contributing to HNSCC.
- Cataloged various immunotherapeutic approaches under investigation.
Conclusions:
- A deeper understanding of HNSCC-associated immune dysfunction is crucial.
- Targeting immune system defects offers promising avenues for improved HNSCC treatment outcomes.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers

